XORTX Therapeutics Inc [NASDAQ: XRTX] closed the trading session at $1.1 on 2025-10-17. The day’s price range saw the stock hit a low of $1.01, while the highest price level was $1.41.
The stocks have a year to date performance of -41.18 percent and weekly performance of 24.87 percent. The stock has been moved at 16.03 percent over the last six months. The stock has performed 27.91 percent around the most recent 30 days and changed 13.40 percent over the most recent 3-months.
If compared to the average trading volume of 63.96K shares, XRTX reached to a volume of 111445835 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about XORTX Therapeutics Inc [XRTX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for XRTX shares is $14.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on XRTX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 2.05, with the Price to Cash per share for the same quarter was set at 0.20.
XRTX stock trade performance evaluation
XORTX Therapeutics Inc [XRTX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 24.87. With this latest performance, XRTX shares gained by 27.91% in over the last four-week period, additionally plugging by 16.03% over the last 6 months – not to mention a drop of -2.62% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for XRTX stock in for the last two-week period is set at 75.07, with the RSI for the last a single of trading hit 0.1066, and the three-weeks RSI is set at 0.0773 for XORTX Therapeutics Inc [XRTX]. The present Moving Average for the last 50 days of trading for this stock 0.8429, while it was recorded at 0.9166 for the last single week of trading, and 0.9208 for the last 200 days.
XORTX Therapeutics Inc (XRTX) Capital Structure & Debt Analysis
According to recent financial data for XORTX Therapeutics Inc. ( XRTX), the Return on Equity (ROE) stands at -79.44%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -49.88%, reflecting the company’s efficiency in generating profits from its assets. Additionally, XORTX Therapeutics Inc’s Return on Invested Capital (ROIC) is -92.63%, showcasing its effectiveness in deploying capital for earnings.
XORTX Therapeutics Inc (XRTX) Efficiency & Liquidity Metrics
Based on XORTX Therapeutics Inc’s (XRTX) latest financial statements, the Debt-to-Equity Ratio is 0.04%, indicating its reliance on debt financing relative to shareholder equity.
XORTX Therapeutics Inc (XRTX) Efficiency & Liquidity Metrics
Earnings per share (EPS) analysis for XORTX Therapeutics Inc [XRTX] stock
With the latest financial reports released by the company, XORTX Therapeutics Inc posted -0.59/share EPS, while the average EPS was predicted by analysts to be reported at -0.84/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.25. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for XRTX.
XORTX Therapeutics Inc [XRTX]: Institutional Ownership
There are presently around $4.64%, or 4.77%% of XRTX stock, in the hands of institutional investors.
